PYC 2.44% 20.0¢ pyc therapeutics limited

It's all Apple's, page-11

  1. ds
    7,131 Posts.
    Agree.

    The real question now is who has the better tech?

    My understanding is the difference between the two (potential and advancement perspective) is not nearly as much as the valuation difference - I only hope it is PYC that gets re-rated one day and not Peptidreams!
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.